Antiviral Drugs Market to reach $63.11 billion by 2022 growing at a CAGR of 5.8%

A new research document with title 'Antiviral Drugs - Global Market Outlook (2016-2022)’ covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions like North America, Europe, Asia Pacific, Rest of the World and important players/vendors such as Abbott Laboratories, AbbVie, Inc., Aurobindo Pharma etc. The report will help user gain market insights, future trends and growth prospects for forecast period of 2016-2022.

Request a sample report @ https://www.htfmarketreport.com/sample-report/626830-antiviral-drugs-global-market-outlook

According to Research, the Global Antiviral market is accounted for $42.65 billion in 2016 and is expected to reach $63.11 billion by 2022 growing at a CAGR of 5.8%. Increased count of people across the globe affecting from influenza, respiratory syncytial virus and epidemic of viral infections had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market.

HIV antivirals segment among applications is expected to dominate the market due to increase in prevalence of HIV infections, and due to growing awareness among people. Moreover, generic drugs segment is expected to witness lucrative growth over the forecast period on account of favorable government regulations. North American market is expected to dominate the global market. However, Asia Pacific is estimated to be the fastest growing region due to growing economies and increased healthcare expenditure in the region.

Some of the key players of the Antiviral Drugs market include Abbott Laboratories, AbbVie, Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Gilead Sciences, GlaxoSmithKline plc., Johnson and Johnson, MedImmune/AstraZeneca, Merck & Co., Mylan N.V., Roche Diagnostics, Schering-Plough and Teva Pharmaceutical Industries Ltd.

Applications Covered:
• Hepatitis-B antivirals
• Hepatitis-C antivirals
• Herpes virus
• HIV antivirals
• Influenza
• Other Applications
o Pneumonia
o Flu

End-Users Covered:
• Ambulatory Surgical Centers
• Clinics
• Hospitals

Distribution Channels covered:
• Hospital Pharmacy Store
• Online Pharmacy
• Retail Pharmacy Store

Product Types Covered:
• Generic Drugs
• Branded Drugs

Action Mechanisms covered:
• Nucleotide polymerase inhibitor
• Protease inhibitors
• Reverse transcriptase inhibitors
• Other Action Mechanisms

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=626830

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/626830-antiviral-drugs-global-market-outlook

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

....Continued

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/626830-antiviral-drugs-global-market-outlook

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

Contact Us:
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road, Edison, NJ USA - 08837
sales@htfmarketreport.com
Ph: +1 (206) 317 1218

This release was published on openPR.